Wells Fargo lowered the firm’s price target on Molina Healthcare (MOH) to $165 from $231 and keeps an Overweight rating on the shares following disappointing Q3 results. While Medicaid remains uncertain in 2026 / 2027, the firm thinks annualized returns as margins begin to recover are fairly interesting at these levels.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- OSCR, ELV, CNC: Health Insurer Stocks on Watch as Trump Pushes ACA Funds Directly to Americans
- Trump Trade: Trump says ‘enrichment’ of health insurers ‘must stop’
- Video: Health insurers weighed on by shutdown news, Trump post
- Wells sees Florida CMS selection as a 3% hit to Centene, 5% tailwind to Molina
- Trump says ‘enrichment’ of health insurers ‘must stop’
